Imaging Potential Evaluation of Fab Derived from the Anti-EGFRvIII Monoclonal Antibody 4G1

Radiation Research
Shen JingXujie Liu

Abstract

As one of the most crucial epidermal growth factor receptor (EGFR) variants, EGFRvIII can be detected in various tumors but rarely in normal tissues, making it an ideal target for prognosis, diagnosis or immune therapy. The recently developed anti-EGFRvIII monoclonal antibody (mAb), 4G1, has been validated as a promising molecular probe to detect EGFRvIII expression in tumors by single-photon emission computed tomography/computed tomography imaging. To overcome shortcomings associated with the whole antibody, including long-term retention, circulation and enhanced permeability and retention effects, the Fab fragment of 4G1 (Fab-4G1) was generated, labeled with 131I and evaluated in vitro and in vivo to test its potential application in molecular imaging. Whole mAb 4G1 was first digested by immobilized ficin and then purified through a protein A column to generate the Fab fragment, Fab-4G1. Next, SDS-PAGE, Western blot, indirect fluorescence assay, flow cytometry and enzyme-linked immunosorbent assay were performed to verify molecular weight, specificity and affinity of Fab-4G1. Finally, biodistribution planar gamma imaging was performed by injection of 131I-labeled Fab-4G1 into xenografted EGFRvIII-overexpressed tumors in nude ...Continue Reading

References

Apr 27, 2001·Radiology·R Weissleder, U Mahmood
Feb 5, 2003·The Journal of Experimental Medicine·Chaity ChaudhuryClark L Anderson
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy B HeimbergerKenneth Aldape
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Dec 24, 2005·Expert Opinion on Drug Delivery·Vania Kenanova, Anna M Wu
Jan 11, 2007·Cancer Research·Mark S DennisRalph Schwall
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ken HerrmannTobias Dechow
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tristan BarrettHisataka Kobayashi
Jan 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ningbo LiuJinming Yu
Mar 28, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hui K GanRodney B Luwor
May 23, 2009·British Journal of Pharmacology·Patrick ChamesDaniel Baty
Oct 15, 2009·Molecular Cancer Therapeutics·Michael M Schmidt, K Dane Wittrup
Jun 15, 2010·Cancer Immunology, Immunotherapy : CII·Lin YangZonghai Li
Oct 12, 2010·BMC Biotechnology·Puja GuptaAlbert J Wong
Nov 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gianfranco Pasut, Francesco M Veronese
Feb 9, 2012·Expert Review of Vaccines·Catherine A Del VecchioAlbert J Wong
Sep 28, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Arne R M van der BiltAnna K L Reyners
Jun 20, 2013·Journal of Alzheimer's Disease : JAD·Kristina MagnussonLars N G Nilsson
Dec 18, 2013·Cell Cycle·Barry Jutten, Kasper M A Rouschop
Aug 28, 2014·Frontiers in Physiology·Angelica M MerlotDes R Richardson
Oct 25, 2014·Neuro-oncology·Kendra L CongdonJohn H Sampson
Apr 18, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sixiang ShiWeibo Cai
May 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura K van DijkJohan Bussink
May 23, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Claudia T MendlerArne Skerra
Jan 20, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jason T YoonRichard L Wahl

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
flow
enzyme-linked immunosorbent assay
electrophoresis
ELISA

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.